Connecticut Clinical Research, Llc

Bridgeport, Connecticut 06606

0 studies enrolling now · 10 studies all time

What they study most

Arthritis, Rheumatoid, Atrial Fibrillation, Atrial Flutter, Cardiovascular Disease, Coronary Artery Disease, High Cardiovascular Risk, Hypertension, Obesity, Overweight, Stroke, Type 2 Diabetes

Studies at this site

• GLORIA-AF Registry Program - Second and Third Phases — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed
• DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension — Completed
• DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension — Stopped early
• Evaluation of Microvolt T-Wave Alternans(MTWA) Testing for the Detection of Active Ischemia — Completed